V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005478 | 280003493 | null | null | Palliative (P) | 2013-02-15 | 2013-03-13 | Ifosfamide PVI 1g/m2 14day | N | null | 280029156 | GEMCARBO |
| 280005479 | 280007855 | 1.87 | 82.4 | Palliative (P) | 2014-09-19 | 2014-09-23 | Docetaxel+Gemcitabine (no prior RT) | N | N | 280029157 | CAPECITABINE + GEMCITABINE |
| 280005480 | 280007855 | 1.64 | 100.4 | Palliative (P) | 2017-11-29 | 2017-12-18 | Enzalutamide | N | N | 280029157 | CAPECITABINE |
| 280005481 | 280003494 | null | 103.05 | Palliative (P) | null | 2014-04-29 | IPILIMUMAB + NIVOLUMAB | Y | null | 280029161 | CARBOPLATIN + DOCETAXEL |
| 280005482 | 280003494 | 1.79 | null | Palliative (P) | 2014-02-04 | 2014-02-22 | Ifosfamide | null | null | 280029161 | CISPLATIN + PEMETREXED |
| 280005483 | 280003494 | 1.74 | 69.4 | Curative (C) | 2015-03-04 | 2015-03-05 | Cisplatin + Etoposide (3 day) | N | N | 280029161 | BCG |
| 280005484 | 280011075 | 1.75 | 66.8 | Palliative (P) | 2015-08-04 | 2015-08-25 | Trabectedin | N | N | 280029165 | CAPECITABINE + CARBOPLATIN |
| 280005485 | 280011075 | 1.71 | 79 | Palliative (P) | 2015-03-06 | 2015-03-06 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 280029165 | CISPLATIN + PEMETREXED |
| 280005486 | 280003495 | 1.63 | 87 | Palliative (P) | 2015-12-29 | 2015-12-29 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 280029169 | OXALIPLATIN + MDG |
| 280005487 | 280003495 | 1.81 | 90 | Palliative (P) | 2018-10-29 | 2018-11-13 | ETOPOSIDE + IFOSFAMIDE | N | N | 280029169 | GEMCARBO |
| 280005488 | 280003495 | 1.66 | 89.9 | Palliative (P) | 2018-06-24 | 2018-06-24 | Doxorubicin + Olaratumab | 2 | N | 280029169 | LANREOTIDE |
| 280005489 | 280003495 | 1.64 | 70.2 | Palliative (P) | 2014-01-11 | 2014-02-26 | Cisplatin + Doxorubicin | N | N | 280029169 | ABIRATERONE |
| 280005490 | 280003495 | 1.87 | 82.95 | Palliative (P) | 2016-05-06 | 2016-05-18 | Doxorubicin + Olaratumab | N | N | 280029169 | DABRAFENIB |
| 280005491 | 280003495 | 1.7 | 77.6 | null | 2014-03-24 | 2014-03-28 | CompARE Trial | N | N | 280029169 | LU-177 |
| 280005492 | 280003495 | 1.97 | 113.9 | Not known (9) | 2017-02-08 | 2017-02-26 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280029169 | LANREOTIDE |
| 280005493 | 280003495 | 1.65 | 55 | null | 2013-08-26 | 2013-09-01 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 280029169 | FLUOROURACIL + MITOMYCIN + RT |
| 280005494 | 280003496 | 0 | null | Not known (9) | 2014-06-28 | 2014-06-28 | Capecitabine + Cisplatin | 2 | N | 280029180 | CAPE + CARBOPLATIN + CETUXIMAB |
| 280005495 | 280007858 | 1.85 | 70 | Palliative (P) | 2017-12-06 | 2017-12-27 | STS Rhabdomyosarcoma RMS 2005 IVADo | Y | N | 280029184 | CARBOPLATIN + PEMETREXED |
| 280005496 | 280003497 | 1.75 | 76 | null | null | 2016-09-05 | EW EuroEwing 2012 Arm A VIDE | N | N | 280029185 | IRINOTECAN + MDG |
| 280005497 | 280003498 | 1.72 | 62 | Palliative (P) | 2014-02-09 | 2014-02-09 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280029186 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 280005498 | 280003498 | 1.58 | 58.9 | null | 2015-08-03 | 2015-08-04 | ECX | 2 | N | 280029186 | PEMBROLIZUMAB |
| 280005499 | 280003498 | null | 58.3 | Curative (C) | 2013-03-03 | 2013-03-03 | Cisplatin + Docetaxel | Y | null | 280029186 | CHOP R |
| 280005500 | 280003498 | null | 70.5 | Palliative (P) | 2017-10-13 | 2017-10-13 | PEMBROLIZUMAB | N | null | 280029186 | CAPECITABINE + OXALIPLATIN |
| 280005501 | 280003499 | 1.7 | 59.4 | null | 2013-04-06 | 2013-04-11 | FLUOROURACIL + MITOMYCIN + RT | N | N | 280029199 | OXALIPLATIN + MDG |
| 280005502 | 280003500 | 1.7 | 45.9 | Palliative (P) | 2016-10-20 | 2016-11-08 | Doxorubicin + Olaratumab | N | N | 280029200 | ECARBOX |
| 280005503 | 280003501 | 1.5 | 68.2 | Palliative (P) | 2013-05-25 | 2014-11-09 | ECX | N | N | 280029201 | CAPECITABINE |
| 280005504 | 280003501 | 1.73 | 89.2 | Palliative (P) | 2016-04-15 | 2016-04-15 | PEMBROLIZUMAB | N | N | 280029201 | SORAFENIB |
| 280005505 | 280003501 | 1.52 | 73 | Adjuvant (A) | 2017-02-06 | 2017-02-06 | Doxorubicin + Olaratumab | N | N | 280029201 | VINORELBINE |
| 280005506 | 280003502 | 1.58 | 57.5 | Palliative (P) | 2017-08-13 | 2017-08-26 | FLUOROURACIL + MITOMYCIN + RT | N | N | 280029209 | OXALIPLATIN + MDG |
| 280005507 | 280003502 | 1.58 | null | null | 2015-08-27 | 2015-08-27 | Oxaliplatin + Modified de Gramont | 02 | N | 280029209 | PANTHER TRIAL |
| 280005508 | 280003503 | 1.53 | 62.5 | Palliative (P) | 2016-11-24 | 2016-12-15 | OCTREOTIDE | N | N | 280029212 | FLUOROURACIL |
| 280005509 | 280003503 | 1.47 | 70.5 | null | 2014-10-13 | 2014-10-27 | CTD (Thalidomide 200mg) | N | N | 280029212 | OXALIPLATIN + MDG |
| 280005510 | 280003504 | 1.8 | null | Palliative (P) | 2015-12-01 | 2015-12-12 | Oxaliplatin + Modified de Gramont | null | null | 280029215 | OCTREOTIDE |
| 280005511 | 280003505 | 1.68 | 97.5 | Palliative (P) | 2013-06-28 | 2013-07-08 | UKALL14- Cons Cycle 1 | 2 | Y | 280029221 | IPILIMUMAB + NIVOLUMAB |
| 280005512 | 280003506 | 1.63 | null | null | 2013-06-11 | 2013-06-12 | MELPHALAN | N | N | 280029223 | ECX |
| 280005513 | 280003507 | -1 | null | Palliative (P) | 2017-03-14 | 2017-03-14 | TEMOZOLOMIDE | 2 | null | 280029229 | CAPECITABINE |
| 280005514 | 280003507 | null | null | null | 2014-09-21 | 2014-09-26 | DE-ESCALATE TRIAL | null | null | 280029229 | CAPECITABINE |
| 280005515 | 280003507 | 1.76 | null | null | 2014-06-01 | 2014-06-16 | Capecitabine 35days + RT | N | N | 280029229 | VEMURAFENIB |
| 280005516 | 280003508 | 1.73 | 86.8 | Curative (C) | 2015-07-22 | 2015-08-02 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280029243 | BCG |
| 280005517 | 280003509 | null | 77.6 | Palliative (P) | 2017-08-03 | 2017-09-04 | Oxaliplatin + Modified de Gramont | Y | N | 280029244 | GEMCARBO |
| 280005518 | 280003509 | 1.64 | 79.7 | Palliative (P) | 2015-07-18 | 2015-08-16 | Doxorubicin + Olaratumab | N | N | 280029244 | CAPECITABINE + GEMCITABINE |
| 280005519 | 280003510 | 1.61 | 75.6 | Curative (C) | 2018-04-14 | 2018-04-17 | Cisplatin + Doxorubicin | 02 | null | 280029246 | BEP |
| 280005520 | 280003510 | null | 82.5 | Palliative (P) | 2013-07-29 | 2013-08-19 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 280029246 | CAPECITABINE + IRINOTECAN |
| 280005521 | 280010014 | 1.6 | 73.8 | Palliative (P) | 2018-06-17 | 2018-06-27 | Oxaliplatin + Modified de Gramont | N | N | 280029254 | AFLIBERCEPT + FU + IRINOTECAN |
| 280005522 | 280003511 | 1.7 | null | null | null | 2016-04-17 | DE-ESCALATE TRIAL | N | null | 280029255 | ECX |
| 280005523 | 280007866 | 1.56 | null | Palliative (P) | 2015-05-20 | 2015-05-20 | MITOMYCIN | N | N | 280029256 | OCTREOTIDE |
| 280005524 | 280003512 | 0.83 | null | Palliative (P) | 2016-01-16 | 2016-01-18 | Paclitaxel 7 day | N | N | 280029257 | LANREOTIDE |
| 280005525 | 280003512 | 1.54 | 0 | Palliative (P) | 2017-04-07 | 2017-05-16 | IMATINIB | N | N | 280029257 | FCARBOST |
| 280005526 | 280003513 | 1.66 | 65.95 | Palliative (P) | 2017-10-29 | 2017-11-12 | Capecitabine + Oxaliplatin 21day | N | N | 280029263 | DACARBAZINE |
| 280005527 | 280003514 | 1.89 | 83.2 | Palliative (P) | null | 2013-11-26 | VAC | 02 | N | 280029268 | CARBOPLATIN + PEMETREXED |